Peripheral intravascular lithotripsy to facilitate transfemoral transcatheter aortic valve replacement – Defining optimal treatable peripheral arterial disease burden

Authors

Stephanie Tom

Published

July 1, 2024

Abstract

Transfemoral transcatheter aortic valve replacement (TF-TAVR) has proven superior to alternative access. However, some patients evaluated for TF-TAVR are unfit secondary to peripheral arterial disease (PAD). Peripheral intravascular lithotripsy (IVL) can facilitate femoral access. This study aimed to characterize optimal lesions that can be treated with IVL.